Cagrilinatide (10mg)
Metabolic Research
Research Use Only — Not for Human or Veterinarian Administration

Cagrilinatide (10mg)

Cagrilintide is an acylated amylin analogue with extended half-life, studied for amylin receptor activation and combination protocols with GLP-1 class compounds in metabolic research.

Cagrilinatide (10mg)$80.00
View only
View Certificate of AnalysisThird-party HPLC lab report · opens PDF

Mechanism of Action

Activates amylin receptors (AMY1/3), slowing gastric emptying and modulating postprandial satiety signals in research models.

Research Applications

  • Amylin receptor binding assays
  • Combination incretin pathway studies
  • Appetite and satiety endpoint research

Specifications

appearanceSee COA for lot-specific appearance and identity confirmation

Reconstitution (Laboratory)

Reconstitute with bacteriostatic water under sterile laboratory conditions unless otherwise specified for your protocol.

Storage & Handling

Lyophilized: 2–8 °C long-term. Reconstituted: refrigerate at 2–8 °C. Protect from light.

Quality Assurance

Every lot undergoes independent third-party HPLC purity analysis, mass spectrometry identity confirmation, and endotoxin testing (<0.5 EU/mg). Certificate of Analysis (COA) is stored against the SKU lot number and available through your research account portal.

Sources & References

  1. 1.Lau J, et al. Cagrilintide: a long-acting amylin analogue. J Med Chem. 2015. · PubMed →
  2. 2.Enebo LB, et al. CagriSema combination therapy. Diabetes Obes Metab. 2021. · PubMed →